Skip to main content
Department of Biochemistry and Molecular Medicine

Department of Biochemistry and Molecular Medicine

News releases

September 2015arrow

New treatments a big step for patients with advanced kidney cancer

September 29, 2015

In an editorial published in the New England Journal of Medicine, Primo Lara, associate director for Translational Research at the UC Davis Comprehensive Cancer Center and David Quinn, medical director, USC Norris Cancer Hospital, highlight two new drugs that have shown great efficacy against kidney cancer.

UC Davis researcher advocates ending Medicare coverage of controversial mammography tool

September 28, 2015

A costly tool used on nearly all mammograms does not increase cancer detection rates and should no longer be covered by Medicare, argues Joshua Fenton, a family physician and comparative effectiveness researcher in an editorial published online today in the Journal of the American Medical Association Internal Medicine.

UC Davis to test a computer program designed to reduce suicide

September 25, 2015

UC Davis Health System researchers have received a four-year, $1.3 million grant from the U.S. Centers for Disease Control and Prevention (CDC) to use a technology-based approach to help prevent suicide among those most at risk: middle-aged men.

Tumor suppressor LRIG1 controls breast cancer aggression and invasion

September 21, 2015

Researchers at UC Davis have shown that the protein LRIG1 reduces breast cancer invasion and could potentially help control metastasis. Using aggressive basal-like breast cancer cell lines, the scientists found that restoring LRIG1 expression reduced these cells’ growth and invasiveness.

UC Davis MIND Institute studies the use of sertaline (Zoloft ®) in young children with autism spectrum disorder

September 18, 2015

Whether the language and social development of very young children with ASD can be improved through treatment with sertraline, commonly known by the brand name Zoloft ®, is the subject of a new clinical trial at the UC Davis MIND Institute.

Cancer Center joins collaborative molecular oncology intiative

September 15, 2015

The UC Davis Comprehensive Cancer Center has joined a unique new collaboration to accelerate the development of precision cancer treatment through the collection and sharing of genomics data

Low vitamin D among the elderly is associated with significant decline in cognition, dementia

September 14, 2015

Vitamin D insufficiency among the elderly is highly correlated with accelerated cognitive decline and impaired performance, particularly in domains such as memory loss that are associated with Alzheimer’s disease and dementia, researchers with the UC Davis Alzheimer’s Disease Center and Rutgers University have found. [en español] [中文 Chinese]

UC Davis study shows popular molecular tests over diagnose C. difficile infections up to 50 percent

September 8, 2015

Clostridium difficile is a common cause of infection and diarrhea in hospitalized patients, but a new study by UC Davis pathologists suggests that many patients are mistakenly diagnosed and do not need antibiotic treatment.

August 2015arrow

UC Davis researchers receive $5.4 million grant to study new tool to evaluate early-stage Alzheimer's

August 31, 2015

Alzheimer’s researchers at UC Davis and UC San Diego have launched a new study which aims to detect the earliest stages of cognitive dysfunction in people with pre-clinical Alzheimer’s disease by using event-related brain potentials (ERPs).

New York Blood Center partners with UC Davis Health System to produce more viable stem cell therapies

August 20, 2015

New York Blood Center (NYBC) today announced a new collaboration with the University of California, Davis, Health System to manufacture specialized lines of stem cells as potential therapies for repair and regeneration of retina, kidney, lung and liver tissue, as well as for the treatment of neurodegenerative disorders such as Parkinson's, Alzheimer's and Huntington's disease.

UC Davis team finds early inflammatory response paralyzes T cells

August 18, 2015

In a discovery that is likely to rewrite immunology text books, researchers at UC Davis have found that early exposure to inflammatory cytokines, such as interleukin 2, can “paralyze” CD4 T cells, immune components that help orchestrate the body’s response to pathogens and other invaders.

UC Davis to employ canines to sniff out cancer

August 17, 2015

UC Davis clinicians are hoping to greatly advance cancer screenings with the innate olfactory skills of man’s best friend.

A better way to personalize bladder cancer treatments

August 13, 2015

Researchers at UC Davis, in collaboration with colleagues at Jackson Laboratory, have developed a new way to personalize treatments for aggressive bladder cancer.

New UC Davis environmental research center links science with advocacy

August 12, 2015

A cross-disciplinary center focused on identifying connections between environmental toxins and disease has been established at UC Davis Health System with the ultimate goal of developing preventions and policies that protect communities from unhealthy exposures.

New combination treatment effective against melanoma skin metastases

August 11, 2015

mIn findings never before seen in melanoma, a novel combination therapy was found to be highly effective at treating patients with skin metastases, new research from UC Davis has shown.

Using kidneys from very small donors for transplant is safer than expected

August 10, 2015

Kidneys transplanted from infants who died of birth-related or other complications are less likely to fail due to a post-surgical vascular complication known as graft arterial stenosis (GAS) than kidneys from deceased adults, resesarchers have found.

UC Davis clinical research scientist wins second Hartwell Foundation award for pediatric cancer research

August 7, 2015

UC Davis pediatric oncologist and researcher Noriko Satake has been awarded a 2015 Hartwell Biomedical Research Collaboration Award from The Hartwell Foundation, a philanthropy that funds innovative and leading-edge biomedical research with the potential to benefit children of the United States. This is the first time a Hartwell investigator from UC Davis has received the Foundation’s inter-institutional Collaboration Award.

Cherry lands top NCI grant

August 6, 2015

Simon Cherry, distinguished professor in the departments of Biomedical Engineering and Radiology, and co-leader of the UC Davis Comprehensive Cancer Center’s Biomedical Technology Program, has been selected to receive a prestigious Outstanding Investigator Award from the National Cancer Institute (NCI).

Raising pay can reduce smoking rates

August 6, 2015

In addition to restricting when and where tobacco is used at work, UC Davis Health System research shows that employers can do something else to reduce the number of employees who smoke: raise wages.

Long-term ovarian cancer survival higher than thought

August 5, 2015

Combing data collected on thousands of California ovarian cancer patients, UC Davis researchers have determined that almost one-third survived at least 10 years after diagnosis.